Namely, we found indications that elevated ST3GAL3 and ST3GAL6 transcripts may be used as surrogates of poor prognosis, underscoring a connection between hypersialylation driven by these glycosyltransferases and CRC aggressiveness. Here, ST3GAL6 is linked to colorectal carcinoma.